News

The agreement also will make Boston Scientific the exclusive distributor for the new ICE catheter optimized for left atrial appendage occlusion workflows.

The U.S. Food and Drug Adminstration (FDA) granted 510(k) clearance for the latest release of Philips Healthcare's Cardiovascular Workspace imaging and information management system. It enables cloud-hosted availability and software-as-a-Service (SaaS) deployment.

The cloud-enabled system provides the foundation for future AI-enabled tools, better workflows and analytics.

Physicians often tell AFib patients they should limit coffee consumption to protect their hearts. This new analysis, however, suggests that may not be necessary.

Researchers used AI-enabled software developed by Cleerly to evaluate the CCTA results of more than 6,000 patients. The software was consistently effective, identifying patients who may face an increased risk of poor outcomes. 

Illustration showing how procizumab captures circulating dipeptidyl peptidase 3 (cDPP3) to block this key molecular driver of shock. Illustrations courtesy of 4TEEN4

Procizumab was developed to change the trajectory of shock by addressing an underlying molecular driver rather than just managing symptoms.

Withings BeamO

BeamO combines electrocardiogram sensors, a stethoscope and a thermometer into a single device that patients can use at home to learn more about their health. Findings can then be submitted for a cardiologist to review.

Samuel Horr

Pulmonary embolism (PE) treatment has evolved over time, yet it remains the third leading cause of cardiovascular death across the United States. TriStar Health, a comprehensive health system serving Tennessee and Kentucky and part of HCA Healthcare, is now using an AI platform to support clinicians in providing more effective care for PE patients.

robotic aortic valve replacement (RAVR)

The WVU Heart and Vascular Institute is hosting a two-day symposium focused on exploring the benefits and long-term potential of robotic aortic valve replacement. Fans of the procedure say it represents a safe, effective alternative to TAVR and SAVR in patients with severe aortic stenosis. 

Thumbnail

The new analysis, published in the New England Journal of Medicine, represents the latest chapter in one of interventional cardiology’s largest ongoing debates.

Thumbnail

Three months of anticoagulation therapy is the go-to option when treating these younger patients—but it could be time for a change.

This trend was even seen in areas where COVID-19 rates were relatively low, researchers found.

Thumbnail

All patients originally presented with a dysfunctional RVOT conduit or stented bioprosthetic pulmonary valve.

Around the web

Researchers recently used advanced 4D flow MRI to track blood in a pulsating artificial heart, revealing dynamics that closely mirror those of a healthy human organ.

Congress needs to act soon to extend telemedicine services that were greatly expanded under COVID provisions, or they will expire by October. Anders Gilberg, senior vice president of government affairs at the Medical Group Management Association, explains concerns raised by doctors and lawmakers.

 

Anders Gilberg, senior vice president of government affairs at the Medical Group Management Association, explains the political and patient care issues involved with ending Affordable Care Act subsidies.